000 01358 a2200373 4500
005 20250511220158.0
264 0 _c19910605
008 199106s 0 0 eng d
022 _a0003-0805
024 7 _a10.1164/ajrccm/143.5_Pt_1.1062
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBjornson, A B
245 0 0 _aComplement is activated in the upper respiratory tract during influenza virus infection.
_h[electronic resource]
260 _bThe American review of respiratory disease
_cMay 1991
300 _a1062-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aComplement Activation
_ximmunology
650 0 4 _aComplement C3a
_xanalysis
650 0 4 _aComplement C5a
_xanalysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfluenza, Human
_ximmunology
650 0 4 _aMale
650 0 4 _aNasal Cavity
_ximmunology
650 0 4 _aPilot Projects
650 0 4 _aRadioimmunoassay
650 0 4 _aSpecimen Handling
650 0 4 _aTherapeutic Irrigation
700 1 _aMellencamp, M A
700 1 _aSchiff, G M
773 0 _tThe American review of respiratory disease
_gvol. 143
_gno. 5 Pt 1
_gp. 1062-6
856 4 0 _uhttps://doi.org/10.1164/ajrccm/143.5_Pt_1.1062
_zAvailable from publisher's website
999 _c2030996
_d2030996